Concepts (95)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antibodies, Viral | 11 | 2023 | 252 | 3.180 |
Why?
|
| Dengue | 9 | 2021 | 93 | 3.020 |
Why?
|
| Dengue Virus | 9 | 2022 | 84 | 2.220 |
Why?
|
| Viral Envelope Proteins | 5 | 2021 | 77 | 1.840 |
Why?
|
| Serologic Tests | 4 | 2020 | 43 | 1.150 |
Why?
|
| Antibodies, Neutralizing | 3 | 2023 | 102 | 1.150 |
Why?
|
| West Nile Fever | 3 | 2021 | 56 | 1.090 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2021 | 445 | 1.030 |
Why?
|
| Antibodies, Monoclonal | 2 | 2018 | 282 | 1.020 |
Why?
|
| Neutralization Tests | 1 | 2021 | 53 | 0.840 |
Why?
|
| Immunoglobulin G | 5 | 2021 | 232 | 0.710 |
Why?
|
| Dengue Vaccines | 1 | 2018 | 13 | 0.680 |
Why?
|
| Cross Reactions | 4 | 2021 | 83 | 0.520 |
Why?
|
| Hypokalemia | 2 | 2004 | 11 | 0.490 |
Why?
|
| Sensitivity and Specificity | 5 | 2021 | 555 | 0.440 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2012 | 108 | 0.430 |
Why?
|
| Viral Nonstructural Proteins | 4 | 2021 | 45 | 0.410 |
Why?
|
| Immunoglobulin M | 2 | 2020 | 81 | 0.350 |
Why?
|
| Respiratory Insufficiency | 2 | 2004 | 13 | 0.300 |
Why?
|
| Humans | 18 | 2023 | 34853 | 0.280 |
Why?
|
| Hydrocortisone | 1 | 2004 | 72 | 0.230 |
Why?
|
| West Nile virus | 2 | 2021 | 65 | 0.230 |
Why?
|
| Blotting, Western | 2 | 2021 | 834 | 0.220 |
Why?
|
| Ammonium Chloride | 1 | 2021 | 4 | 0.210 |
Why?
|
| Convalescence | 1 | 2021 | 7 | 0.210 |
Why?
|
| Defective Viruses | 1 | 2021 | 10 | 0.210 |
Why?
|
| Lentivirus | 1 | 2021 | 20 | 0.210 |
Why?
|
| Antigen-Antibody Reactions | 1 | 2021 | 20 | 0.210 |
Why?
|
| Vero Cells | 1 | 2021 | 90 | 0.210 |
Why?
|
| Point Mutation | 1 | 2021 | 88 | 0.210 |
Why?
|
| Genes, Reporter | 1 | 2021 | 132 | 0.200 |
Why?
|
| Genetic Vectors | 1 | 2021 | 154 | 0.200 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2021 | 168 | 0.200 |
Why?
|
| Asthma | 1 | 2004 | 363 | 0.180 |
Why?
|
| Common Variable Immunodeficiency | 1 | 2019 | 27 | 0.180 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2019 | 57 | 0.180 |
Why?
|
| Autoimmunity | 1 | 2019 | 52 | 0.180 |
Why?
|
| Microspheres | 1 | 2019 | 45 | 0.180 |
Why?
|
| Immunoassay | 1 | 2019 | 57 | 0.170 |
Why?
|
| Virion | 1 | 2018 | 67 | 0.170 |
Why?
|
| Algorithms | 1 | 2020 | 435 | 0.160 |
Why?
|
| HIV-1 | 1 | 2021 | 678 | 0.140 |
Why?
|
| Animals | 3 | 2021 | 14307 | 0.140 |
Why?
|
| Mutation | 1 | 2019 | 1023 | 0.130 |
Why?
|
| Adult | 5 | 2018 | 11034 | 0.130 |
Why?
|
| Hypokalemic Periodic Paralysis | 2 | 2004 | 3 | 0.120 |
Why?
|
| Epitopes | 1 | 2013 | 145 | 0.110 |
Why?
|
| Antibody Affinity | 1 | 2012 | 25 | 0.110 |
Why?
|
| Protein Stability | 1 | 2012 | 40 | 0.110 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2012 | 40 | 0.110 |
Why?
|
| Protein Structure, Secondary | 1 | 2012 | 172 | 0.110 |
Why?
|
| Mice | 2 | 2013 | 5668 | 0.110 |
Why?
|
| Lymphocyte Activation | 2 | 2019 | 222 | 0.100 |
Why?
|
| Protein Binding | 1 | 2012 | 913 | 0.090 |
Why?
|
| Gene Expression | 1 | 2012 | 639 | 0.090 |
Why?
|
| Female | 3 | 2017 | 19873 | 0.090 |
Why?
|
| Acute Disease | 2 | 2004 | 141 | 0.070 |
Why?
|
| Male | 5 | 2019 | 18870 | 0.070 |
Why?
|
| Membrane Proteins | 2 | 2022 | 486 | 0.060 |
Why?
|
| Thyrotoxicosis | 1 | 2004 | 3 | 0.060 |
Why?
|
| Hypercapnia | 1 | 2004 | 8 | 0.060 |
Why?
|
| Alkalosis | 1 | 2004 | 1 | 0.060 |
Why?
|
| Heat Stroke | 1 | 2004 | 1 | 0.060 |
Why?
|
| Phagocytosis | 1 | 2004 | 64 | 0.060 |
Why?
|
| Cell Adhesion Molecules | 1 | 2004 | 70 | 0.060 |
Why?
|
| Half-Life | 1 | 2023 | 52 | 0.060 |
Why?
|
| Pituitary Neoplasms | 1 | 2003 | 5 | 0.060 |
Why?
|
| Thyrotropin | 1 | 2003 | 15 | 0.060 |
Why?
|
| Viral Matrix Proteins | 1 | 2022 | 17 | 0.050 |
Why?
|
| Sucrose | 1 | 2022 | 27 | 0.050 |
Why?
|
| Virus Assembly | 1 | 2022 | 38 | 0.050 |
Why?
|
| Adenoma | 1 | 2003 | 89 | 0.050 |
Why?
|
| Vaccination | 1 | 2023 | 259 | 0.050 |
Why?
|
| Pedigree | 1 | 2019 | 64 | 0.050 |
Why?
|
| Immunologic Memory | 1 | 2019 | 38 | 0.050 |
Why?
|
| Combined Modality Therapy | 1 | 2019 | 142 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2019 | 92 | 0.040 |
Why?
|
| High-Throughput Screening Assays | 1 | 2019 | 63 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2019 | 485 | 0.040 |
Why?
|
| Genotype | 1 | 2019 | 641 | 0.040 |
Why?
|
| Phenotype | 1 | 2019 | 650 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2019 | 1349 | 0.030 |
Why?
|
| Membranes | 1 | 2014 | 18 | 0.030 |
Why?
|
| Protein Precursors | 1 | 2014 | 59 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 1 | 2014 | 383 | 0.030 |
Why?
|
| Aged | 1 | 2004 | 6448 | 0.030 |
Why?
|
| Cell Line | 1 | 2014 | 1289 | 0.020 |
Why?
|
| Middle Aged | 1 | 2003 | 9642 | 0.020 |
Why?
|
| Potassium Chloride | 1 | 2004 | 25 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2004 | 74 | 0.020 |
Why?
|
| Potassium | 1 | 2004 | 110 | 0.010 |
Why?
|
| Lymphocytes | 1 | 2004 | 116 | 0.010 |
Why?
|
| Neutrophils | 1 | 2004 | 124 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2003 | 211 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2003 | 468 | 0.010 |
Why?
|